Nuwellis (NUWE) EBITDA Margin Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | -3,057.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,057.00 |
| Dec 31, 2025 | -3,410.00 |
| Sep 30, 2025 | -7,839.00 |
| Jun 30, 2025 | -37,581.00 |
| Mar 31, 2025 | 7,525.00 |
| Dec 31, 2024 | 15,516.00 |
| Sep 30, 2024 | 23,917.00 |
| Jun 30, 2024 | -11,874.00 |
| Mar 31, 2024 | 12,155.00 |
| Dec 31, 2023 | -14,044.00 |
| Sep 30, 2023 | 4,759.00 |
| Jun 30, 2023 | -3,982.00 |
| Mar 31, 2023 | -12,286.00 |
| Dec 31, 2022 | 18,724.00 |
| Sep 30, 2022 | 9,720.00 |
| Jun 30, 2022 | -499.00 |
| Mar 31, 2022 | 4,002.00 |
| Dec 31, 2021 | -5,510.00 |
| Sep 30, 2021 | -6,040.00 |
| Jun 30, 2021 | 2,199.00 |
| Mar 31, 2021 | 806.00 |
| Dec 31, 2020 | 11,562.00 |
| Sep 30, 2020 | 13,596.00 |
| Jun 30, 2020 | 5,371.00 |
| Mar 31, 2020 | 10,879.00 |
| Dec 31, 2019 | -4,169.00 |
| Sep 30, 2019 | -4,884.00 |
| Jun 30, 2019 | 11,628.00 |
| Mar 31, 2019 | 3,055.00 |
| Dec 31, 2018 | 57,491.00 |
| Sep 30, 2018 | -1,363.00 |
| Jun 30, 2018 | -9,555.00 |
| Mar 31, 2018 | -31,533.00 |
| Dec 31, 2017 | -47,023.00 |
| Sep 30, 2017 | 42,487.00 |
| Mar 31, 2015 | -118,983.00 |
| Sep 30, 2014 | 14,407.00 |